Search Results 991-1000 of 14706 for استخدام حبوب منع الحمل
Male or female patients of child-producing potential must agree to use contraception or avoidance of pregnancy measures during the study and for 30 days after ...
... pregnant or suspect that she is pregnant while participating on the trial, she should inform her treating physician immediately. ... Any use of this site ...
Currently pregnant or planning pregnancy in the next 2 years. Prisoner or a ... Any use of this site constitutes your agreement to the Terms and ...
These samples will be used for future biomarker discovery and other translational studies. Gynecologic Extramammary Paget's Disease. Rochester, Minn. In ...
... prevent postoperative Staphylococcus aureus ... Male subjects and female subjects of childbearing potential and at risk for pregnancy must agree to use a highly ...
... pregnancy test prior to randomization. If the urine test cannot be confirmed as negative, a serum pregnancy test will be required. ... Any use of this site ...
The purpose of this pilot project is to identify digital biomarkers associated with opioid withdrawal severity and buprenorphine response (withdrawal relief).
Female subject who is pregnant or lactating or who does not agree to use an effective method of contraception, e.g., hormonal contraception or double-barrier ...
... use of PDOs as a new personalized therapy ... Women known to be pregnant. Non-English speaking ... Any use of this site constitutes your agreement to ...
Skip to site navigation ... Female participants of childbearing potential (WOCBP) must have a negative urine or serum pregnancy ... Any use of this site constitutes ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.